| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 48,296,000 | 48,418,000 | 48,371,000 | | Cost of Revenue | 8,112,000 | 11,239,000 | 7,640,000 | | | Gross Profit | 40,184,000 | 37,179,000 | 40,731,000 | | | Operating Expenses | | Research Development | 7,945,000 | 8,089,000 | 7,599,000 | | Selling General and Administrative | 14,537,000 | 15,626,000 | 15,589,000 | | Non Recurring | 3,308,000 | 2,817,000 | 2,158,000 | | Others | 2,668,000 | 3,128,000 | 3,261,000 | | | | Total Operating Expenses | 28,458,000 | 29,660,000 | 28,607,000 | | | | Operating Income or Loss | 11,726,000 | 7,519,000 | 12,124,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,516,000) | 2,156,000 | 1,392,000 | | Earnings Before Interest And Taxes | 10,210,000 | 9,675,000 | 13,516,000 | | Interest Expense | 516,000 | 397,000 | 488,000 | | Income Before Tax | 9,694,000 | 9,278,000 | 13,028,000 | | Income Tax Expense | 1,645,000 | 1,023,000 | 1,992,000 | | Minority Interest | (23,000) | (42,000) | (12,000) | | | | Net Income From Continuing Ops | 8,026,000 | 8,213,000 | 11,024,000 | | | Non-recurring Events | | Discontinued Operations | 78,000 | (69,000) | 8,313,000 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 8,104,000 | 8,144,000 | 19,337,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,104,000 | $8,144,000 | $19,337,000 |
|
1.29% Nasdaq 0.00%
Income Statement
